Use of the Quantra QPlus Sytem in Cardiac Surgery

HemoSonics

Status: Completed

Conditions: Cardiovascular Diseases

Treatments: Diagnostic Test: Quantra QPlus System

Study type: Observational

Funder types: Industry

Identifiers

NCT05501730

HEMCS-038

Details and patient eligibility

About

Single center retrospective study evaluating the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.

Full description

Yavapai Regional Medical Center (YRMC) implemented the Quantra QPlus System to aid in their efforts to effectively reduce the transfusion rate of allogenic blood products and improve outcomes in patients undergoing cardiac surgery. Use of the Quantra to guide decisions related to the use of blood products in cardiac surgery patients began in 2019. In this retrospective study, YRMC evaluated the impact of using the Quantra QPlus System to guide transfusion decisions on postoperative outcomes in patients undergoing cardiac surgery.

Enrollment: 128 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

• Pre-Quantra Group: All consecutive patients undergoing cardiac surgical procedures during the period from January 2019 to September 2019 (n=64)
• Post-Quantra Group: All consecutive patients undergoing cardiac surgical procedures during the period from May 2020 to April 2021 (n=64)

Trial design

128 participants in 2 patient groups

Pre-Quantra

Description:

Patients undergoing cardiac surgery prior to the introduction of the Quantra.

Post-Quantra

Description:

Patients undergoing cardiac surgery after the introduction of the Quantra.

Treatment:

Diagnostic Test: Quantra QPlus System